RTI Surgical Q2 revenue shrinks to $70.7M: 5 details

Mackenzie Garrity -   Print  |

RTI Surgical released its 2018 second quarter financial results.

Here are five details:

1. Worldwide revenues for the second quarter were $70.7 million, compared to $72.1 million in the same quarter the prior year.

2. Excluding the company's $3.7 million reduction from the sale of all assets from the cardiothoracic business closure, RTI Surgical's total revenues increased 3.3 percent year-over-year to $2.2 million.

3. RTI Surgical reported $30 million in gross profits. Excluding the excess inventory charge and purchase accounting impact, the company's adjusted gross profit was $36.8 million compared to $37 million in the same period in 2017.

4. Net loss regarding common shares was $6.4 million, or $0.10 per diluted common share in the second quarter.

5. At the end of the year, RTI Surgical expects its revenues to range between $280 million and $290 million.

To view the full financial report, click here.

More articles on devices and implants:
NuVasive reports $282M in Q2 revenue — Up 8.5%
Stryker, Zimmer Biomet, Smith & Nephew & more: 9 device company notes
What to expect from NuVasive for 2nd half of 2018 and beyond: 7 key points

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers